Short-term Efficacy of High-flow Nasal Cannula Oxygen Thera-py Combined with Glucocorticoid in the Treatment of Severe Asthma and Its Effect on Inflammatory Factors
Short-term Efficacy of High-flow Nasal Cannula Oxygen Thera-py Combined with Glucocorticoid in the Treatment of Severe Asthma and Its Effect on Inflammatory Factors
Objective To investigate the short-term effect of high-flow nasal cannula oxygen therapy(HFNC)com-bined with Glucocorticoid in the treatment of severe asthma and their effect on the level of inflammatory factors.Methods A total of 100 patients with severe asthma admitted from May 2020 to May 2022 were randomly divided into observation group and control group,with 50 patients in each group.The control group was treated with Methylprednisolone and the observation group was treated with HFNC on the basis of the control group.The clinical efficacy,blood gas indexes[arterial partial pres-sure of oxygen(PaO2),arterial partial pressure of carbon dioxide(PaCO2),blood oxygen saturation(SpO2)],inflammatory factors and the occurrence of adverse reactions were compared between the two groups.Results The total effective rate of observa-tion group[96.00%(48/50)]was significantly higher than that of control group[82.00%(41/50)](P<0.05).PaO2 and SpO2 were higher in observation group than in the control group while PaCO2 was lower in observation group than in the control group(P<0.05).After treatment,the level of inflammatory factors in observation group was lower than that in control group(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion HFNC combined with Glucocorticoids is more effective in the treatment of severe asthma patients,which can significantly improve the respiratory function of patients,regulate the level of inflammatory factors,and do not increase adverse reactions.
关键词
哮喘/糖皮质激素/经鼻高流量湿化氧疗/Toll样受体4/白细胞介素-6/嗜酸粒细胞/干扰素-γ
Key words
Asthma/Glucocorticoid/High-flow nasal cannula oxygen therapy/Toll like receptor 4/Interleukin-6/Eosinophil/Interferon-γ